ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 42 filers reported holding ADC THERAPEUTICS SA in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,288,000 | -27.3% | 1,517,212 | 0.0% | 4.35% | +37.3% |
| Q4 2021 | $30,648,000 | -25.6% | 1,517,212 | 0.0% | 3.17% | -37.2% |
| Q3 2021 | $41,207,000 | +11.5% | 1,517,212 | 0.0% | 5.05% | +37.6% |
| Q2 2021 | $36,944,000 | -0.2% | 1,517,212 | 0.0% | 3.67% | +34.9% |
| Q1 2021 | $37,035,000 | -23.7% | 1,517,212 | 0.0% | 2.72% | +2.8% |
| Q4 2020 | $48,566,000 | -3.0% | 1,517,212 | 0.0% | 2.65% | -28.3% |
| Q3 2020 | $50,053,000 | -16.3% | 1,517,212 | +18.8% | 3.69% | -33.7% |
| Q2 2020 | $59,786,000 | – | 1,277,212 | – | 5.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |